We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Coping With Stress may Improve HDL Levels

By HospiMedica staff writers
Posted on 15 Oct 2007
A new study has found evidence to suggest that people who cope with stress well may have higher high-density lipoprotein (HDL) cholesterol levels than people who let the stress affect them. More...


Scientists from the University of Hawaii (Manoa, HI, USA) examined 716 men, almost all of them white (average age of 65), who took part in a long-term study on aging. Each was asked to describe his most stressful situation encountered in the previous week and was asked to choose among 26 strategies for coping with stress. Those strategies were scored on the basis of hostility the men displayed and other characteristics. Blood samples were taken from the men after an overnight fast and measured for levels of HDL cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides.

The study found that lower levels of HDL were found in the men who used hostility as a coping strategy, and also in those demonstrating self-blame and self-isolation. Those strategies did slightly raise levels of triglycerides, but had no effect on LDL readings (which conversely often goes hand-in-hand with increases in HDL cholesterol). The researchers speculated that men who keep a level head and control their hostility avoid increasing levels of stress hormones such as cortisol, which affect blood fat levels. The study was presented at the 115th Annual Convention of the American Psychological Association, held during August 2007 in San Francisco (CA, USA).

"The personality trait of emotional stability is protective against mortality. Those men who were good in self-regulation had higher HDL levels,” said lead author Loriena A. Yancura, Ph.D., a University of Hawaii psychologist.

LDL, considered "bad cholesterol, forms deposits on the artery walls, which produce plaque. HDL, the "good” cholesterol, on the other hand, removes excess cholesterol and carries it back to the liver to be excreted; high levels of HDL in the blood can decrease the risk of heart disease.


Related Links:
University of Hawaii

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.